Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-12-30 4:30 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | RA CAPITAL MANAGEMENT L.P. | 5,454,533 8.21% | 5,454,533 (New Position) | View |
2022-12-27 4:15 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | Cormorant Asset Management LP | 2,762,115 5.07% | 750,000 (+37.27%) | View |
2022-08-18 3:38 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | Cowen Financial Products LLC | 3,264,150 6.56% | 3,264,150 (New Position) | View |
2022-08-10 2:56 pm Sale | 13G | AVIDITY BIOSCIENCES INC RNA | PRICE T ROWE ASSOCIATES INC | 5,079,526 10.2% | -2,652,320 (-34.30%) | View |
2022-02-14 3:06 pm Sale | 13G | AVIDITY BIOSCIENCES INC RNA | Cormorant Asset Management LP | 2,012,115 4.29% | -452,432 (-18.36%) | View |
2022-02-14 3:03 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | EcoR1 Capital LLC | 2,759,505 5.9% | 655,555 (+31.16%) | View |
2022-02-14 2:35 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | PRICE T ROWE ASSOCIATES INC | 7,731,846 16.4% | 1,916,636 (+32.96%) | View |
2022-02-14 1:12 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | FEDERATED HERMES INC. FHI | 2,474,500 5.28% | 2,474,500 (New Position) | View |
2022-02-10 4:21 pm Unchanged | 13G | AVIDITY BIOSCIENCES INC RNA | ELI LILLY & Co LLY | 2,319,396 4.9% | 0 (Unchanged) | View |
2022-02-09 09:09 am Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | FMR LLC | 3,776,524 8.052% | 352,389 (+10.29%) | View |
2022-02-03 4:41 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | BlackRock Inc. BLK | 3,297,480 7% | 1,268,223 (+62.50%) | View |
2021-09-10 1:36 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | PRICE T ROWE ASSOCIATES INC | 5,815,210 12.7% | 5,815,210 (New Position) | View |
2021-02-16 3:10 pm Sale | 13G | AVIDITY BIOSCIENCES INC RNA | Cormorant Asset Management LP | 2,464,547 6.57% | -49,998 (-1.99%) | View |
2021-02-16 12:10 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | EcoR1 Capital LLC | 2,103,950 5.6% | 2,103,950 (New Position) | View |
2021-02-12 4:43 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | ELI LILLY & Co LLY | 2,319,396 6.2% | 2,319,396 (New Position) | View |
2021-02-08 10:17 am Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | FMR LLC | 3,424,135 9.124% | 591,283 (+20.87%) | View |
2021-02-02 3:13 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | BlackRock Inc. BLK | 2,029,257 5.4% | 2,029,257 (New Position) | View |
2020-07-10 11:38 am Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | FMR LLC | 2,832,852 7.552% | 909,887 (+47.32%) | View |
2020-06-26 4:17 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | Cormorant Asset Management LP | 2,514,545 6.7% | 2,514,545 (New Position) | View |
2020-06-22 09:14 am Purchase | 13D | AVIDITY BIOSCIENCES INC RNA | RTW INVESTMENTS LP | 3,995,000 11.3% | 3,995,000 (New Position) | View |